Tech Transfer eNews Blog
Industry-Sponsored Research Management

Encore presentation of CRISPR Confusion: A Legal and Practical Analysis for IP Professionals


By Jesse Schwartz
Published: November 8th, 2017

CRISPR technology holds the promise of providing researchers and technologists with the most powerful genetic tool since the biotechnology revolution began forty years ago. However, legal disputes over patent rights have clouded the prospects for broad dissemination of the technology. In particular, the two university owners of the patents and applications for CRISPR, MIT/Harvard’s Broad Institute and the University of California-Berkeley, have been locked in a bitter interference over which group of inventors has priority.

The Patent Trial and Appeal Board decided earlier this spring that there was no interference between the competing claims. But this is not a best outcome for potential licensees, leaving open the prospect that separate licenses will be needed from both patent owners. The case has not only complicated the promulgation and commercialization of CRISPR-based research, it is also raising important issues surrounding patent practice and licensing, particularly in biotech.

In June Technology Transfer Tactics’ Distance Learning Division featured Kevin E. Noonan, partner with McDonnell Boehnen Hulbert & Berghoff LLP and Chair of the firm’s Biotechnology & Pharmaceuticals Practice Group, to lead this critical and timely webinar: CRISPR Confusion: A Legal and Practical Analysis for IP Professionals. Based on extremely high interest and customer demand, we’re offering an encore of the recorded program on Tuesday, November 14. For complete program details and to register, CLICK HERE.

ALSO COMING SOON:

Posted under: Distance Learning, Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment